Critical Path Institute (C-Path) is an independent, nonprofit organization established in 2005 as a public and private partnership. C-Path’s mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. An international leader in forming collaborations, C-Path has established numerous global consortia that currently include more than 1,600 scientists from government and regulatory agencies, academia, patient organizations, disease foundations, and dozens of pharmaceutical and biotech companies. C-Path U.S. is headquartered in Tucson, Arizona and C-Path, Ltd. EU is headquartered in Dublin, Ireland, with additional staff in multiple other locations. For more information, visit c-path.org and c-path.eu.

Life Sciences

Critical Path Institute (C-Path)

Daniel M. Jorgensen

Nicholas Ambrose

Denise Ballesteros

Michael Minchik

Julie Strzyzewski

Klaus Romero

Thom H.

Steven Broadbent

Kristen Swingle

Rick Liwski

The Quantitative Medicine team at Critical Path Institute (C-Path) specializes in the application of advanced mathematical and computational techniques to analyze and interpret biomedical data. This team's primary focus is on pharmacometrics to accelerate drug development and regulatory decision-making by creating predictive models and simulations. Their work involves close collaboration with scientists from various sectors to develop quantitative tools that inform clinical trials and regulatory strategies.

Quantitative Medicine

Project Management

Science and Research

Data and Information Technology Team

Quantitative Medicine

About

Team members

Other teams at Critical Path Institute (C-Path)

Project Management

Science and Research

Data and Information Technology Team